MiniBinders: A novel approach to extracellular protein degradation
We have identified a novel modality that is well-suited for targeted protein degradation.
We have identified and characterized E3 ligases expressed on cancer cells, opening up the door to new targets and indications.
CargoTek: Re-doseable AAV therapies
Demonstrated re-dosing of AAV in mice with CargoTek.
Entered into a strategic research collaboration with AAV company.